Expanding the Promise of Immunotherapy

Leveraging elite immune responses to develop novel cancer immunotherapies


The Right People in the Right Place at the Right Time

Making advancements in immuno-oncology through strategic partnerships



October 10, 2016
OncoResponse Secures $7M in Supplemental Series A Funding

May 26, 2016
OncoResponse Secures Investment from Baxalta